Structure | Catalog | Product Name | CAS | E3 Ligase | Target | Inquiry |
---|---|---|---|---|---|---|
![]() |
BPL-201113 | d9A-2 | 2690350-15-1 | CRBN |
SLC9A1 |
Inquiry |
![]() |
BPL-201114 | d9A-3 | 2640254-11-9 | CRBN |
SLC9A1 |
Inquiry |
![]() |
BPL-201115 | d9A-4 | 2640254-12-0 | CRBN |
SLC9A1 |
Inquiry |
![]() |
BPL-201116 | d9A-5 | 2640254-10-8 | CRBN |
SLC9A1 |
Inquiry |
![]() |
BPL-201117 | TL13-117 | CRBN |
BLK |
Inquiry | |
![]() |
BPL-201118 | TL13-148 | CRBN |
FLT3 |
Inquiry | |
![]() |
BPL-201119 | TL13-149 | 2801715-14-8 | CRBN |
FLT3 |
Inquiry |
![]() |
BPL-201120 | JB-4-048 | CRBN |
FLT3 |
Inquiry | |
![]() |
BPL-201121 | JB-4-049 | 2769852-42-6 | CRBN |
FLT3 |
Inquiry |
![]() |
BPL-201122 | JB-4-050 | CRBN |
FLT3 |
Inquiry | |
![]() |
BPL-201123 | JB-4-066 | CRBN |
FLT3 |
Inquiry | |
![]() |
BPL-201124 | JB-4-072 | CRBN |
FLT3 |
Inquiry | |
![]() |
BPL-201125 | JB-4-073 | CRBN |
FLT3 |
Inquiry | |
![]() |
BPL-201126 | CJH-005-067 | 2102694-54-0 | CRBN |
BTK |
Inquiry |
![]() |
BPL-201127 | DD-04-015 | CRBN |
BTK |
Inquiry | |
![]() |
BPL-201128 | ZNL-02-012 | 2414418-43-0 | CRBN |
Wee1 |
Inquiry |
![]() |
BPL-201129 | ZNL-02-047 | 2414418-48-5 | CRBN |
Wee1 |
Inquiry |
![]() |
BPL-201130 | ZNL-02-040 | 2414418-47-4 | CRBN |
Wee1 |
Inquiry |
![]() |
BPL-201131 | N1-(2-(1-(3-Bromo-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide | 2447066-15-9 | CRBN |
PD-L1 |
Inquiry |
![]() |
BPL-201132 | 5-(4-(1-(3-Bromo-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-5-oxopentanamide | 2447066-16-0 | CRBN |
PD-L1 |
Inquiry |